Publications
Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN. Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer. Breast cancer research and treatment. 2007. PMID: 17952589
Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer. 2007. PMID: 17847016
Bashoura L, Gupta S, Jain A, Couriel DR, Komanduri KV, Eapen GA, Safdar A, Broglio KR, Adachi R, Dickey BF. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone marrow transplantation. 2007. PMID: 17934530
Philips GK, Halabi S, Sanford BL, Bajorin D, Small EJ, Cancer and Leukaemia Group B. A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102. BJU international. 2007. PMID: 17922873
Smith RP, Schuchert M, Komanduri K, Burton S, Heron DE, Luketich JD, d'Amato T, Landreneau R. Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032. Annals of surgical oncology. 2007. PMID: 17909906
Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. Journal of immunotherapy (Hagerstown, Md. : 1997). 2007. PMID: 17893568
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, Fox Chase Cancer Center Partners. Colon cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2007. PMID: 17977501
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP, National Comprehensive Cancer Network. Rectal cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2007. PMID: 17977503
Homsi J, Simon GR, Garrett CR, Springett G, De Conti R, Chiappori AA, Munster PN, Burton MK, Stromatt S, Allievi C, Angiuli P, Eisenfeld A, Sullivan DM, Daud AI. Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007. PMID: 17908979
Jim HS, Andrykowski MA, Munster PN, Jacobsen PB. Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2007. PMID: 17927558
James Rubenstein, Lauren Abrey, Ranjana Advani, Marc Shuman, Tony Tsai, Joan O'Brien. In Reply. Journal of Clinical Oncology. 2007. PMID:
Small EJ, Fontana J, Tannir N, DiPaola RS, Wilding G, Rubin M, Iacona RB, Kabbinavar FF. A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer. BJU international. 2007. PMID: 17822457
Hsieh AC, Small EJ, Ryan CJ. Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development. The Lancet. Oncology. 2007. PMID: 17913662
Halabi S, Ou SS, Vogelzang NJ, Small EJ. Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer. Cancer. 2007. PMID: 17665494
Lin AM, Small EJ. Management of hormone refractory prostate cancer. Current opinion in supportive and palliative care. 2007. PMID: 18685361
Choo SP, Venook AP. An alternative therapy for patients with hepatic impairment? Onkologie. 2007. PMID: 17890884
Panchal H, Wansbury O, Parry S, Ashworth A, Howard B. Neuregulin3 alters cell fate in the epidermis and mammary gland. BMC developmental biology. 2007. PMID: 17880691
Shah NP. Progressive thoughts about progressive disease. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007. PMID: 17875748
Guo F, Letrent SP, Munster PN, Britten CD, Gelmon K, Tolcher AW, Sharma A. Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety. Cancer chemotherapy and pharmacology. 2007. PMID: 17805538
Lown BA, Chou CL, Clark WD, Haidet P, White MK, Krupat E, Pelletier S, Weissmann P, Anderson MB. Caring attitudes in medical education: perceptions of deans and curriculum leaders. Journal of general internal medicine. 2007. PMID: 17786522